Filing Details

Accession Number:
0001104659-14-020863
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-19 12:19:38
Reporting Period:
2014-03-18
Filing Date:
2014-03-19
Accepted Time:
2014-03-19 12:19:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1497504 Dipexium Pharmaceuticals Inc. DPRX Pharmaceutical Preparations (2834) 271707962
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1127423 J Robert Deluccia 40 Washington Street
Suite 220
Wellesley Hills MA 02481
Executive Chairman Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $.001 Per Share Acquisiton 2014-03-18 2,083 $12.00 1,813,669 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $.001 Per Share Employee Stock Option (right to buy) Acquisiton 2014-03-18 298,826 $0.00 298,826 $13.93
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
298,826 2019-03-18 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, Par Value $.001 Per Share 17,640 Indirect By Spouse
Footnotes
  1. Excludes 5,600 shares beneficially owned by family members of the Reporting Person, for which the Reporting Person maintains voting control but no pecuniary interest, and disclaims beneficial ownership therein.
  2. The option vests in 36 equal monthly installments, with the first installment vesting on April 18, 2014.